| Literature DB >> 8846649 |
Abstract
As one proposes sometimes more aggressive immunomodulatory treatment early in the process of rheumatoid arthritis, it becomes necessary to think about the prognostic factors early in the disease process that can predict eventual later poor outcome. We summarize the literature of the last 10 years dealing with this topic.Entities:
Mesh:
Substances:
Year: 1995 PMID: 8846649 DOI: 10.1007/bf02215853
Source DB: PubMed Journal: Clin Rheumatol ISSN: 0770-3198 Impact factor: 2.980